![](/img/cover-not-exists.png)
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial
Kerwin, Edward M, Boucot, Isabelle H, Vogelmeier, Claus F, Maltais, Francois, Naya, Ian P, Tombs, Lee, Jones, Paul W, Lipson, David A, Keeley, Tom, Bjermer, LeifVolume:
14
Journal:
Therapeutic Advances in Respiratory Disease
DOI:
10.1177/1753466620926949
Date:
January, 2020
File:
PDF, 444 KB
2020